Compare OBK & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OBK | OGN |
|---|---|---|
| Founded | 1912 | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.5B |
| IPO Year | 2018 | 2020 |
| Metric | OBK | OGN |
|---|---|---|
| Price | $46.23 | $11.22 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 4 |
| Target Price | ★ $45.20 | $11.75 |
| AVG Volume (30 Days) | 176.9K | ★ 6.9M |
| Earning Date | 04-22-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.15% | 0.93% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 2.40 | 0.72 |
| Revenue | N/A | ★ $6,216,000,000.00 |
| Revenue This Year | $26.43 | $0.45 |
| Revenue Next Year | $5.79 | $1.67 |
| P/E Ratio | $19.26 | ★ $11.92 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $31.21 | $5.69 |
| 52 Week High | $46.64 | $13.25 |
| Indicator | OBK | OGN |
|---|---|---|
| Relative Strength Index (RSI) | 67.05 | 73.69 |
| Support Level | $34.78 | $6.31 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 1.06 | 0.75 |
| MACD | 0.18 | 0.27 |
| Stochastic Oscillator | 83.47 | 95.83 |
Origin Bancorp Inc is a financial holding company that provides personalized, relationship banking to businesses, municipalities, and personal clients in the communities it serves. The company offers a broad range of financial services and operates more than 56 locations in Dallas/Fort Worth, East Texas, Houston, North Louisiana, Mississippi, South Alabama, and the Florida Panhandle. It also provides insurance agency products and services through its wholly owned insurance agency subsidiary. The company operates in one business segment, community banking, and is mainly engaged in attracting deposits from individuals and businesses and using these deposits and borrowed funds to originate commercial, residential mortgage, construction, and consumer loans.
Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.